Frontiers in Immunology (Nov 2023)

Purinergic P2X7 receptor expression increases in leukocytes from intra-abdominal septic patients

  • Helios Martínez-Banaclocha,
  • Carlos García-Palenciano,
  • Carlos García-Palenciano,
  • Laura Martínez-Alarcón,
  • Joaquín Amores-Iniesta,
  • Fátima Martín-Sánchez,
  • Giovanni A. Ercole,
  • Ada González-Lisorge,
  • José Fernández-Pacheco,
  • Piedad Martínez-Gil,
  • Julio Padilla-Rodríguez,
  • Alberto Baroja-Mazo,
  • Pablo Pelegrín,
  • Pablo Pelegrín,
  • Juan José Martínez-García,
  • Juan José Martínez-García

DOI
https://doi.org/10.3389/fimmu.2023.1297249
Journal volume & issue
Vol. 14

Abstract

Read online

Inflammation is a tightly coordinated response of the host immune system to bacterial and viral infections, triggered by the production of inflammatory cytokines. Sepsis is defined as a systemic inflammatory response followed by immunosuppression of the host and organ dysfunction. This imbalance of the immune response increases the risk of mortality of patients with sepsis, making it a major problem for critical care units worldwide. The P2X7 receptor plays a crucial role in activating the immune system by inducing the activation of peripheral blood mononuclear cells. In this study, we analyzed a cohort of abdominal origin septic patients and found that the expression of the P2X7 receptor in the plasma membrane is elevated in the different subsets of lymphocytes. We observed a direct relationship between the percentage of P2X7-expressing lymphocytes and the early inflammatory response in sepsis. Additionally, in patients whose lymphocytes presented a higher percentage of P2X7 surface expression, the total lymphocytes populations proportionally decreased. Furthermore, we found a correlation between elevated soluble P2X7 receptors in plasma and inflammasome-dependent cytokine IL-18. In summary, our work demonstrates that P2X7 expression is highly induced in lymphocytes during sepsis, and this correlates with IL-18, along with other inflammatory mediators such as IL-6, IL-8, and procalcitonin.

Keywords